Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,497 | 231 | 99.5% |
| Education | $19.01 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $608.78 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $400.46 | 26 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $325.47 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $303.05 | 20 | $0 (2024) |
| ABBVIE INC. | $302.84 | 15 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $178.50 | 17 | $0 (2021) |
| Lilly USA, LLC | $154.61 | 11 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $143.89 | 3 | $0 (2021) |
| Amgen Inc. | $140.85 | 8 | $0 (2022) |
| Merck Sharp & Dohme LLC | $136.64 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $300.16 | 17 | ABBVIE INC. ($82.90) |
| 2023 | $434.18 | 23 | AbbVie Inc. ($137.62) |
| 2022 | $403.49 | 25 | Bayer HealthCare Pharmaceuticals Inc. ($136.03) |
| 2021 | $689.23 | 37 | Biohaven Pharmaceuticals, Inc. ($143.89) |
| 2020 | $302.62 | 22 | Novo Nordisk Inc ($87.86) |
| 2019 | $276.67 | 19 | Amgen Inc. ($37.81) |
| 2018 | $629.18 | 51 | Novo Nordisk Inc ($153.54) |
| 2017 | $480.87 | 40 | Janssen Pharmaceuticals, Inc ($102.74) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Diabetes | ||||||
| 11/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: Cardio-renal | ||||||
| 11/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Cardio-renal | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: Cardio-renal | ||||||
| 07/26/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Gastroenterology | ||||||
| 07/25/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Cardio-renal | ||||||
| 06/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Diabetes | ||||||
| 05/22/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.93 | General |
| Category: Diabetes Care | ||||||
| 02/19/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Gastroenterology | ||||||
| 02/06/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: VACCINE | ||||||
| 01/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: NEUROSCIENCE | ||||||
| 01/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY, SHINGRIX | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: RESPIRATORY | ||||||
| 11/28/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: Diabetes | ||||||
| 11/16/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Cardio-renal | ||||||
| 09/26/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/20/2023 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $18.99 | General |
| Category: Endocrinology | ||||||
| 08/29/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 08/24/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.92 | General |
| Category: NEUROSCIENCE | ||||||
| 08/23/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Cardio-renal | ||||||
| 08/15/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 13 | 22 | $220.00 | $48.40 |
| 2022 | 3 | 112 | 129 | $6,955 | $4,939 |
| 2021 | 4 | 231 | 259 | $13,240 | $9,361 |
| 2020 | 4 | 203 | 243 | $12,580 | $8,828 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 81003 | Automated urinalysis test | Office | 2023 | 13 | 22 | $220.00 | $48.40 | 22.0% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2022 | 49 | 57 | $3,415 | $2,909 | 85.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 49 | 57 | $3,390 | $1,998 | 58.9% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 15 | $150.00 | $33.08 | 22.1% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2021 | 98 | 107 | $6,420 | $5,490 | 85.5% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 98 | 106 | $6,360 | $3,745 | 58.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 22 | 32 | $320.00 | $93.92 | 29.3% |
| 81003 | Automated urinalysis test | Office | 2021 | 13 | 14 | $140.00 | $31.50 | 22.5% |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | Office | 2020 | 83 | 97 | $5,820 | $4,977 | 85.5% |
| 87426 | Coronavirus ag ia | Office | 2020 | 93 | 106 | $6,360 | $3,745 | 58.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 14 | 25 | $250.00 | $72.27 | 28.9% |
| 81003 | Automated urinalysis test | Office | 2020 | 13 | 15 | $150.00 | $33.60 | 22.4% |
About Dr. William Ashburn, MD
Dr. William Ashburn, MD is a Family Medicine healthcare provider based in Barbourville, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1356327456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Ashburn, MD has received a total of $3,516 in payments from pharmaceutical and medical device companies, with $300.16 received in 2024. These payments were reported across 234 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,497).
As a Medicare-enrolled provider, Ashburn has provided services to 559 Medicare beneficiaries, totaling 653 services with total Medicare billing of $23,176. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Barbourville, KY
- Active Since 12/20/2005
- Last Updated 03/22/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356327456
Products in Payments
- Kerendia (Drug) $325.47
- FARXIGA (Drug) $240.99
- Victoza (Drug) $220.02
- Ozempic (Drug) $217.05
- VRAYLAR (Drug) $204.73
- NURTEC ODT (Drug) $176.11
- TRELEGY ELLIPTA (Drug) $171.34
- XARELTO (Drug) $140.38
- INGREZZA (Drug) $133.95
- UBRELVY (Drug) $126.70
- SYMBICORT (Drug) $115.09
- TRULICITY (Drug) $113.43
- Rybelsus (Drug) $104.67
- JANUVIA (Drug) $87.04
- CHANTIX (Drug) $83.52
- JARDIANCE (Drug) $79.90
- ANORO (Drug) $70.32
- Prolia (Biological) $63.28
- Aimovig (Biological) $61.12
- MYRBETRIQ (Drug) $51.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Barbourville
Dr. Richard Carter, Md, MD
Family Medicine — Payments: $6,787
Dr. Paul Cooney, Do, DO
Family Medicine — Payments: $3,276
Dr. Charles Stargel, Md, MD
Family Medicine — Payments: $1,424
Dr. Elizabeth Douglas, Md, MD
Family Medicine — Payments: $1,185
Tyler Carter, Do, DO
Family Medicine — Payments: $434.46
Dr. David Worthy, Md, MD
Family Medicine — Payments: $196.13